Oral Ozempic-like Pills Offer Hope for Diabetes and Obesity Treatment.

Researchers presented data in two studies on Sunday at the American Diabetes Association Scientific Sessions conference, one of which showed that 50 milligrams of semaglutide — the active compound in Ozempic and Wegovy — taken orally each day is roughly as effective as weekly Wegovy shots in reducing weight in people who are overweight or obese. A separate study focused on oral semaglutide for people with Type 2 diabetes. The higher the dose of oral semaglutide, the more side effects seem to come with it.